ACLS Pharmacology Form A (Latest 2023 - 2024)
Actual Questions and Answers 100% Correct
1. ADENOSINE
indications for use
Answer: *First drug for most forms of stable narrow complex SVT.
*Effective in terminating those due to reentry involving AV node or sinus node.
2. AMIODARONE
indications for use
Answer: *VF/pulseless VT unresponsive to shock delivery, CPR,
and a vasopressor.*Recurrent, hemodynamically unstable VT
3. ATROPINE SULFATE
indications for use
Answer: *First drug for symptomatic bradycardia
*May be beneficial in pressence of AV nodal block *Organophosphate poisoning
4. DOPAMINE
indications for use
Answer: *Second line drug for symptomatic bradycardia
*For hypotension with signs and symptoms of shock
5. EPINEPHRINE
indications for use Answer: *Cardiac arrest: VF, pulseless VT, asystole, PEA *Symptomatic bradycardia *Severe hypotension *Anaphylaxis, severe allergic reactions
6. LIDOCAINE
indications for use 1 / 2
Answer: *Alternative to amiodarone in cardiac arrest from VF/VT
*Stable monophasic VT with preserved ventricular function *Stable polymorphic VT with normal baseline QT interval & preserves LV function *Stable polymorphic VT with baseline QT-interval prolongation if torsades suspect- ed
7. MAGNESIUM SULFATE
indications for use
Answer: *For use in cardiac arrest only if torsades-de-pointes or
suspected hypomagnesemia present *Life threatening ventricular arrhyhmias due to digitalis toxicity
8. VASOPRESSIN
indications for use
Answer: *Alternative to epinephrine in treatment of adult shock
refractory VF *Alternative to epinphrine in asystole, PEA *Useful for hemodynamic support in vasodilatory shock
9. ADENOSINE
adult dosage
Answer: *Initial bolus of 6 mg given RAPIDLY OVER 1 TO 3
SECONDS
followed by 20 ml bolus of NS, then elevate extremity *Second dose of 12 mg can be given after 1 to 2 minutes if needed
10. AMIODARONE
adult dosage
Answer: *VF/VT Cardiac Arrest* First dose 300 mg IV/IO push,
Second dose if needed 150 mg IV/IO push *Life Tnhreatening Arrhythmias* 2.2 g IV over 24 hours. Rapid
infusion: 150 mg IV over 10 minutes, may repeat every 10 minutes.
Slow infusion: 360 mg IV over 6 hours. Maintenamce infusion: 540 mg IV over 18 hours.
- / 2